You have 9 free searches left this month | to do more

selinexor

Selinexor is a drug used to treat Multiple Myeloma, Acute Myeloid Leukemia, Glioblastoma, and other conditions. Selinexor is being actively studied in 47 studies and prior, has been studied in 21.

Top SponsorsTop SitesTop Investigators
Karyopharm Therapeutics IncMemorial Sloan Kettering Cancer CenterBhavana Bhatnagar
H. Lee Moffitt Cancer Center and Research InstituteH. Lee Moffitt Cancer Center and Research InstituteErin Bertino
St. Jude Children's Research HospitalDana Farber Cancer InstituteDavid E Gerber
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
U
Recruiting
  • Soft Tissue Sarcoma
  • +3 more
  • Selinexor
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
2022-04-07
Apr 7, 2022
M
Withdrawn
  • Solid Tumor Malignancy
  • Hackensack, New Jersey
    John Theurer Cancer Center at HackensackUMC
2021-12-14
Dec 14, 2021
U
Completed
  • Soft Tissue Sarcoma
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
2021-11-26
Nov 26, 2021
J
Recruiting
  • Multiple Myeloma
  • Selinexor
  • +4 more
  • Shanghai, Shanghai, China
    Shanghai Changzheng Hospital
2022-03-03
Mar 3, 2022
H
Not yet recruiting
  • Extramedullary Multiple Myeloma
  • (no location specified)
2022-01-20
Jan 20, 2022
G
Terminated
  • Colorectal Neoplasm
  • Selinexor
  • +3 more
  • Antwerpen, Belgium
  • +1 more
2022-02-07
Feb 7, 2022
W
Recruiting
  • Amyloid
  • +2 more
  • New York, New York
  • +1 more
2022-01-20
Jan 20, 2022
N
Recruiting
  • Gliosarcoma
  • +2 more
  • Selinexor
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022
H
Active, not recruiting
  • Leukemia
  • +2 more
  • Selinexor
  • +2 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
2021-11-15
Nov 15, 2021
W
Recruiting
  • Myeloma Multiple
  • +2 more
  • Selinexor
  • +3 more
  • Brooklyn, New York
  • +1 more
2022-01-20
Jan 20, 2022
U
Recruiting
  • Primary Myelofibrosis
  • +2 more
  • Selinexor
  • Salt Lake City, Utah
    Huntsman Cancer Institute/University of Utah
2021-09-27
Sep 27, 2021
H
Active, not recruiting
  • Multiple Myeloma
  • Selinexor
  • +2 more
  • Tampa, Florida
  • +1 more
2022-01-11
Jan 11, 2022
G
Recruiting
  • Sarcoma,Soft Tissue
  • Selinexor
  • Barcelona, Spain
  • +5 more
2021-11-16
Nov 16, 2021
H
Active, not recruiting
  • Multiple Myeloma
  • Selinexor
  • +4 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
2021-11-18
Nov 18, 2021
G
Completed
  • Acute Myeloid Leukemia (Relapsed/Refractory)
  • Selinexor
  • +2 more
  • Frankfurt am Main, Hessen, Germany
  • +2 more
2021-08-01
Aug 1, 2021
N
Not yet recruiting
  • Anaplastic Astrocytoma
  • +4 more
  • Radiation Therapy
  • Selinexor
  • (no location specified)
2022-03-11
Mar 11, 2022
M
Recruiting
  • Recurrent Histiocytic and Dendritic Cell Neoplasm
  • +3 more
  • Choline Salicylate
  • Selinexor
  • Rochester, Minnesota
    Mayo Clinic in Rochester
2022-04-04
Apr 4, 2022
N
Completed
  • Peripheral T-cell Lymphoma
  • Selinexor
  • ICE Chemotherapy
  • Singapore, Singapore
    National Cancer Centre Singapore
2021-04-27
Apr 27, 2021
T
Completed
  • B-cell Lymphoma
  • selinexor
  • +6 more
  • Bruxelles, Belgium
  • +7 more
2021-12-06
Dec 6, 2021
U
Recruiting
  • Non-small Cell Lung Cancer
  • Aurora, Colorado
  • +3 more
2022-03-22
Mar 22, 2022
N
Recruiting
  • Advanced Refractory Solid Tumors
  • +2 more
  • Singapore, Singapore
    National University Hospital
2021-08-31
Aug 31, 2021
S
Recruiting
  • Acute Leukemia of Ambiguous Lineage in Relapse
  • +3 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
2021-11-18
Nov 18, 2021